Feature | ASTRO | October 30, 2018

Late-breaking Radiation Therapy Clinical Trials at ASTRO 2018

ASTRO 2018 Radiation Therapy Clinical Trials. #ASTRO2018 #ASTRO18 #ASTRO

October 30, 2018 — The American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting included 10 top-rated clinical studies. The ASTRO 2018 annual meeting, held Oct. 21-23 in San Antonio, Texas drews more than 11,000 attendees.

The highlighted studies below are linked to full articles. 

 

Advances in Breast and Lung Cancers

Sunday, Oct. 21

 

Advances in Genitourinary Cancers

Monday, Oct. 22

 

Advances in Oral and Oligometastatic Cancers

Tuesday, Oct. 23

 

Other ASTRO News and Videos:

Trends in Proton Therapy at ASTRO 2018 — Faster Therapy Delivery, Single-room Installs

 

SBRT Considered Safe Treatment Option for Patients With Multiple Metastases

VIDEO: Radiation Oncology Reimbursement Update From ASTRO — Interview with Anne Hubbard, MBA, ASTRO director of health policy

Hippocampal Sparing Prevents Whole-Brain Radiotherapy Cognitive Side Effects

VIDEO: Biologically Guided Radiation Therapy Using Real-time PET Imaging — Interview with Kristin Higgens, M.D., Emory 

Smart Machines To Empower Oncology Docs and Patients, Say ASTRO Experts

VIDEO: Beaumont's Experience With Proton Therapy After One Year — Interview with Peyman Kabolizadeh, M.D., Beaumont Proton Therapy Center

Biology Guided Radiotherapy May Improve Physician Confidence in Treatment of Multiple Tumors

VIDEO: The Use of Nanoparticles in Radiation Therapy — Interview with James Welsh, M.D., MD Anderson Cancer Center

Market for MRI-based RT Could Soon Widen

VIDEO: FDA-cleared Bra Helps Improve Breast Positioning During Radiation Therapy — Interview with Elizabeth Chabner-Thompson, M.D., MPH

Prostate Brachytherapy Shows Low Incidence of Short-Term Complications

VIDEO: Use of Liquid Biopsies to Assess Radiotherapy Response — Interview with Aadel Chaudhuri, M.D.

360 View of the Dedicated Radiotherapy Magnetom Sola 1.5T MRI System

VIDEO: Personalizing Radiotherapy Using Genomic Markers of Radiosensitivity — Interview with Javier Torres-Roca, M.D.

VIDEO: Improving Breast Cancer Surgery With Electronic Brachytherapy IORT —  Interview with A. M. Niser Syed, M.D.

360 View of a GE Healthcare Discovery RF Gen 2 Dedicated Radiation Therapy CT System
 

 

 

For more information: www.astro.org

Related Content

University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
AI Biomarker Demonstrates High Predictive Power for Lung Cancer Immunotherapy
News | Artificial Intelligence | May 31, 2019
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at...
A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing  synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of  the anatomy.

A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of the anatomy.

Feature | Radiation Oncology | May 29, 2019 | By Jeff Zagoudis
Dynamic Digital Radiography Used to Assess Undifferentiated Dyspnea
News | Digital Radiography (DR) | May 29, 2019
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described...
Leica Biosystems Receives FDA Clearance for Aperio AT2 DX Digital Pathology System
Technology | Digital Pathology | May 29, 2019
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin